Shoulder Innovations CFO granted 126,357 stock options

Shoulder Innovations, Inc. granted Chief Financial Officer Jeffrey S. Points a stock option on January 30, 2026.

Accepted by SEC EDGAR 02/03/2026 - 04:43 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Shoulder Innovations, Inc. granted Chief Financial Officer Jeffrey S. Points a stock option on January 30, 2026. The option covers 126,357 shares of common stock at an exercise price of $14.16 per share.

The option is held directly and vests in four equal annual installments, with one-fourth of the underlying shares vesting on March 1 each year, beginning March 1, 2027. After this grant, Points beneficially owns 126,357 stock options tied to common shares.

Insider Trade Summary

Grant/Award: 126,357 shares

Grant/Award 1 txn

Insider Points Jeffrey S.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	126,357	$0.00	$0.00

Holdings After Transaction: Stock Option — 126,357 contracts (Direct)

Holdings Before and After: Stock Option, 0 to 126,357 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Shoulder Innovations (SI) disclose in this Form 4 filing?

Shoulder Innovations disclosed that its Chief Financial Officer, Jeffrey S. Points, received a stock option grant. The option covers 126,357 common shares at a $14.16 exercise price and is held directly. The filing outlines vesting terms beginning in 2027.

How many shares are covered by Jeffrey S. Points’ new stock option at SI?

The new stock option granted to Jeffrey S. Points covers 126,357 shares of Shoulder Innovations common stock. These are derivative securities that give him the right to purchase shares at a fixed $14.16 exercise price, subject to the vesting schedule described in the filing.

What is the exercise price of the CFO’s stock option at Shoulder Innovations (SI)?

The stock option granted to Shoulder Innovations’ CFO has an exercise price of $14.16 per share. This price is the amount he must pay per share to acquire common stock when the option becomes exercisable under the vesting schedule starting in 2027.

When does the newly granted stock option to SI’s CFO begin vesting?

The stock option begins vesting on March 1, 2027. One-fourth of the underlying shares vests on March 1 each year, so the option will vest in four equal annual installments, as described in the footnote to the Form 4 filing.

How is the CFO’s ownership of the stock option in SI reported?

The Form 4 reports that Jeffrey S. Points holds the stock option directly. After the reported grant, he beneficially owns 126,357 derivative securities in the form of stock options, each linked to one share of Shoulder Innovations common stock, subject to vesting.

What transaction code is used for the SI CFO’s stock option grant?

The transaction is coded as “A” on the Form 4, indicating an acquisition of derivative securities. This reflects the grant of a stock option to the Chief Financial Officer rather than an open-market purchase or sale of existing common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Points Jeffrey S.

(Last) (First) (Middle)

C/O SHOULDER INNOVATIONS, INC.

1535 STEELE AVENUE SW, SUITE B

(Street)

GRAND RAPIDS MI 49507

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHOULDER INNOVATIONS, INC. [ SI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$14.16	01/30/2026		A		126,357		(1)	01/30/2033	Common Stock	126,357	$0	126,357	D

Explanation of Responses:

1. The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.

Remarks:

	/s/ Jeffrey S. Points	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.